Literature DB >> 8885793

Natural history of cervical neoplasia: overview and update.

N Kiviat1.   

Abstract

Current cervical cancer control strategies and specifically, the screening and treatment policies that have been used during the past 30 years, are based on an understanding of the natural history of cervical neoplasia that does not take into account the important role of human papillomavirus in cervical cancer pathogenesis. This survey presents a review of new data on the causes of cervical cancer and the role of human papillomavirus and recommends the integration of these data. Incorporation of new information on the role of human papillomavirus as the causative agent of most cervical cancers will allow the design of more efficient and more cost-effective strategies for cervical cancer control.

Entities:  

Mesh:

Year:  1996        PMID: 8885793     DOI: 10.1016/s0002-9378(96)70011-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour.

Authors:  F Fylan
Journal:  Br J Gen Pract       Date:  1998-08       Impact factor: 5.386

2.  Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.

Authors:  Tanvier Omar; Sheree Schwartz; Colleen Hanrahan; Tebogo Modisenyane; Nkeko Tshabangu; Jonathan E Golub; James A McIntyre; Glenda E Gray; Lerato Mohapi; Neil A Martinson
Journal:  AIDS       Date:  2011-01-02       Impact factor: 4.177

3.  Progression or Regression? - Strengths and Weaknesses of the New Munich Nomenclature III for Cervix Cytology.

Authors:  Z Hilal; C Tempfer; S Schiermeier; J Reinecke; C Ruppenkamp; Z Hilal
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

4.  Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.

Authors:  D C Swan; R A Tucker; G Tortolero-Luna; M F Mitchell; L Wideroff; E R Unger; R A Nisenbaum; W C Reeves; J P Icenogle
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 5.  Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

Authors:  J P A Baak; A-J Kruse; S J Robboy; E A M Janssen; B van Diermen; I Skaland
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

6.  Familial cervical cancer: case reports, review and clinical implications.

Authors:  Margreet Zoodsma; Rolf H Sijmons; Elisabeth Ge de Vries; Ate Gj van der Zee
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

7.  HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.

Authors:  J K Chan; B J Monk; C Brewer; K A Keefe; K Osann; S McMeekin; G S Rose; M Youssef; S P Wilczynski; F L Meyskens; M L Berman
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

8.  Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.

Authors:  V T Nghiem; K R Davies; J R Beck; M Follen; C MacAulay; M Guillaud; S B Cantor
Journal:  Br J Cancer       Date:  2015-04-28       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.